Difficulty: Medium
Average Score: 70%
Practice
This drug acts by inhibiting type III cyclic nucleotide phosphodiesterase:
Correct answer
B
Rationale
In the context of ATI Pharmacology Across the Lifespan, the correct answer to the question is B) Milrinone. Milrinone is a phosphodiesterase inhibitor that specifically targets type III cyclic nucleotide phosphodiesterase. Understanding the mechanism of action of drugs is crucial in pharmacology as it determines their therapeutic effects and potential side effects.
Amiodarone (A) is a class III antiarrhythmic drug that works by blocking potassium channels. Propranolol (C) is a non-selective beta-blocker that acts on beta-adrenergic receptors. Enalapril (D) is an angiotensin-converting enzyme (ACE) inhibitor that inhibits the conversion of angiotensin I to angiotensin II.
Educationally, knowing the specific mechanisms of action of drugs helps healthcare professionals make informed decisions when selecting appropriate medications for patients based on their conditions. It also aids in understanding potential drug interactions and adverse effects. Therefore, understanding the mechanism of action of milrinone as a type III cyclic nucleotide phosphodiesterase inhibitor is vital in the pharmacological management of patients.
Amiodarone (A) is a class III antiarrhythmic drug that works by blocking potassium channels. Propranolol (C) is a non-selective beta-blocker that acts on beta-adrenergic receptors. Enalapril (D) is an angiotensin-converting enzyme (ACE) inhibitor that inhibits the conversion of angiotensin I to angiotensin II.
Educationally, knowing the specific mechanisms of action of drugs helps healthcare professionals make informed decisions when selecting appropriate medications for patients based on their conditions. It also aids in understanding potential drug interactions and adverse effects. Therefore, understanding the mechanism of action of milrinone as a type III cyclic nucleotide phosphodiesterase inhibitor is vital in the pharmacological management of patients.